Abstract: An aerosol generating device and an operation method thereof are disclosed. The aerosol generating device may include a heater for heating an aerosol generating material, a battery for supplying power to the heater, and a controller for dividing a preheating period for preheating the heater into a plurality of sections and controlling so that more power is supplied to the heater in a first section than in a second section among the plurality of sections.

Abstract: An aerosol generating device includes a main body and a cartridge detachably coupled to the main body. The main body includes a controller, a battery, and a first wireless communication unit. The cartridge includes a second wireless communication unit. The controller controls output power of the battery to apply a power pattern to the cartridge, and the first wireless communication unit establishes a wireless connection with the second wireless communication unit when power supplied from the battery to the cartridge matches a preset power pattern.

Abstract: The present disclosure relates to a method for carrying out dose delivery quality assurance for high-precision radiation treatment, in which parameters affecting a pass rate of dose delivery quality assurance can be derived through regression analysis, which is a known statistical analysis method, and a pass rate prediction model capable of predicting each parameter and the pass rate of dose delivery quality assurance can be derived, and accordingly, it can be predicted in advance whether dose delivery quality assurance will be passed according to the parameters through the above prediction model, without repeatedly carrying out dose delivery quality assurance according to a patient's treatment plan, and as a result, the efficiency of dose delivery quality assurance can be enhanced, and the time or capacity required for such quality assurance is reduced, such that radiation treatment for an actual patient can be quickly and precisely carried out.

Abstract: A medical powder spraying device with easy control of the flow volume of the powder being sprayed and an operating method of the powder spraying device are disclosed. The powder spraying device is characterized by including a flow volume control means, and thus the flow volume of the powder being sprayed may be more easily controlled.

Abstract: An absorbent bone hemostatic material composition and a method for preparing the composition are disclosed. The composition includes an antibiotic and absorbent bone hemostatic materials that provide a physical protective film for stopping bone hemorrhage during surgery. Thus, the composition containing the absorbent bone hemostatic materials and antibiotic exhibits an immediate hemostatic effect and prevent infection and inflammatory response at the surgical site.

Abstract: In a connector module coupled to a printed circuit board including a terminal hole, the connector module comprises: a bracket including a first body and a second body; a bus bar disposed in the bracket and being protruded outside the first body; and a pin disposed in the second body and connected to the bus bar, wherein the bus bar comprises: an upper plate part disposed on an upper surface of the printed circuit board; a connection part bent from one end of the upper plate part and coupled to the terminal hole; and a bent part bent from the other end of the upper plate part and surrounding the side surface of the printed circuit board.

Abstract: A topical hemostatic powder composition and a preparation method for manufacturing the powder composition are disclosed. The powder-type hemostatic agent includes a superabsorbent polymer and a bioadhesive polymer (BP). The power-type hemostatic agent is biodegradable in vivo and superb in terms of hemostasis effectiveness, thereby suitable for various applications in surgical procedures and minimal invasive surgery such as endoscopy, laparoscopy, and the like.

Abstract: The present invention relates to a multi-use hemostatic composition and a method for producing the same, and more particularly, to a technique relating to a multi-use a hemostatic agent in which a first component having a modified anionized substituent and a second component that is a polymer having adhesiveness are included to provide improved hemostatic ability and biocompatibility so as to have applicability into surgery, laparoscopy, and various surgical procedures.

Abstract: An atmosphere purification reactor using an electron beam and an atmosphere purification apparatus including the same are disclosed. The atmosphere purification reactor using an electron beam according to an exemplary embodiment of the present invention includes a housing which has a predetermined length and is formed to have a hollow form such that a fluid introduced from an outside passes through the housing, a guide part which is disposed in the housing in a longitudinal direction and guides a moving path of the fluid such that the fluid moves while rotating, and a transmissive part which is provided at one side of the housing so as to transmit an electron beam into the housing.

Abstract: Provided is a security checking system. The security checking system includes an electron beam acceleration unit for accelerating electron beams having at least one energy intensity, an X-ray guide unit converting the electron beams accelerated by the electron beam acceleration unit into X-rays to guide the converted X-rays into an object, a neutron guide unit, and a detection unit detecting the X-rays and neutrons passing through the object. Thus, nuclear materials within the object may be detected, and also, maintenance/repair costs may be inexpensive to improve economic feasibility.

Abstract: Provided is a security checking system. The security checking system includes an electron beam acceleration unit for accelerating electron beams having at least one energy intensity, an X-ray guide unit converting the electron beams accelerated by the electron beam acceleration unit into X-rays to guide the converted X-rays into an object, a neutron guide unit, and a detection unit detecting the X-rays and neutrons passing through the object. Thus, nuclear materials within the object may be detected, and also, maintenance/repair costs may be inexpensive to improve economic feasibility.

Abstract: A patch antenna synchronously generating a circularly polarized wave and a linearly polarized wave comprises a first radiator radiating a circularly polarized wave with respect to an antenna signal, a first substrate provided at a part or the whole of the rear surface of the first radiator, a second radiator provided at a part or the whole of the rear surface of the first substrate and radiating a linearly polarized wave with respect to the antenna signal, and a second substrate provided at a part or the whole of the rear surface of the second radiator.

Abstract: A disclosed is a vehicle terminal, which is capable of using hard keys configured to be arranged and modified according to a user's taste. In particular, the spatial arrangement of the hard keys may be changed, as well as their appearance.

Abstract: The present invention provides a metallic laminate and a method for preparing the same. The metallic laminate includes a metal layer, and at least one polymide resin layer. The polymide resin layer has a modulus of elasticity of 70 Mpa at 400° C.

Abstract: A mobile terminal having a touch function is presented. The mobile terminal includes a display unit to display one or more content on a screen and a storage box positioned on the screen for storing at least one of the one or more content dragged on the screen.

Abstract: A liquid target producing device to which multiple capillary tubes are mountable includes a capillary tube for injecting a liquid target in a jet form; a gas storage tank connected to the capillary tube through a gas line to store a gas to be supplied to the capillary tube; a metal jacket positioned at an outer circumference of the capillary tube such that a plurality of capillary tubes are installable thereto, the metal jacket liquefying the gas supplied through the gas line; a cryo-cooler connected to the metal jacket through a thermal conductive wire to cool the metal jacket; and a moving means for moving the metal jacket so as to set an initial position of the capillary tube.

Abstract: The present invention provides a photosensitive resin composition comprising: a polyamic acid including a specific repeating unit; a heterocyclic amine compound; a (metha)acrylate-based compound including one or more double bonds between carbons; a photoinitiator; and an organic solvent, and a dry film prepared therefrom. The photosensitive resin composition can be cured at a low temperature to offer process safety and work convenience, and has excellent bending resistance, soldering heat resistance, and a property of filling the pattern, as well as excellent heat resistance and mechanical properties.

Abstract: The present invention provides a metallic laminate and a method for preparing the same. The metallic laminate includes a metal layer, and at least one polymide resin layer. The polymide resin layer has a modulus of elasticity of 70 Mpa at 400° C.

Abstract: The present invention provides a metallic laminate and a method for preparing the same. The metallic laminate includes a metal layer, and at least one polyimide resin layer. The polyimide resin layer has a modulus of elasticity of 70 Mpa at 400° C.

Abstract: This invention relates to a series of substituted cyclohexane containing analogues which are agonists of GPR119 intended to treat metabolic diseases mediated by GPR119 including Type I & II diabetes mellitus. Diabetes mellitus is an ever-increasing threat to human health causing various complications (blindness, kidney failure, neuropathy, heart attack, stroke, etc.). Recently it was found that activation of GPR119 which is highly expressed in pancreatic beta cells causes glucose dependent insulin secretion and GLP-1 release. Many pharmaceuticals are currently developing GPR119 agonists and herein we disclose alternative GPR119 agonists. Our invention describes GPR119 agonists having structural Formula (I), pharmaceutically acceptable salt or solvate of Formula (I), isomer or prodrug of Formula (I), and combination therapy of Formula (I) with other anti-diabetic drugs like DPP-IV inhibitors and/or insulin sensitizers.